ISSN 2756-3340
African Journal of Infectious Diseases Research | Vol. 12, No. 9, September 2025 | pp. 761–767
DOI: 10.46882/AJIDR/148872
Article Type: Original Article
Title: Seroprevalence and risk factors of Hepatitis D virus co-infection among chronic Hepatitis B surface antigen carriers
Names of Authors: Amina Suleiman¹*, Lucas Moreau²
Authors’ Affiliations: ¹Department of Gastroenterology and Hepatology, Ahmadu Bello University, Zaria, Nigeria. ²Department of Virology, University of Lyon, Lyon, France.
Abstract: Hepatitis D virus co-infection accelerates liver fibrosis progression and hepatocellular carcinoma risk in individuals living with chronic hepatitis B. We evaluated anti-HDV seroprevalence, active HDV RNA viremia, and hepatic fibrosis severity among HBsAg-positive outpatients. Serum specimens from 420 chronic hepatitis B patients were screened via enzyme-linked immunosorbent assay and quantitative reverse transcription polymerase chain reaction. Anti-HDV antibodies were detected in 9.8 percent of participants, with active HDV RNA confirmed in 63.4 percent of seropositive cases and significantly elevated liver stiffness scores. Universal reflex anti-HDV screening for all HBsAg-positive patients is strongly recommended.
Keywords: Hepatitis D virus, Hepatitis B co-infection, Viral hepatitis, Liver cirrhosis, Seroprevalence
Citation: Suleiman A, Moreau L (2025). Seroprevalence and risk factors of Hepatitis D virus co-infection among chronic Hepatitis B surface antigen carriers. African Journal of Infectious Diseases Research, 12(9): 761–767. DOI: 10.46882/AJIDR/148872
Manuscript Timeline: Received: July 18, 2025; Revised: August 19, 2025; Accepted: September 01, 2025; Published: September 06, 2025
Subscribe to read the full article: https://mail.internationalscholarsjournals.org/subscribe-to-read